Abdulqadir Nashwan
@anashwan.bsky.social
Honored to be named among the Top 2% of Scientists worldwide (2025) in the @stanfordpress.bsky.social University & @elsevierconnect.bsky.social global database. Even more special to be one of only 16 scientists from Hamad Medical Corporation to receive this recognition. 💙💚
September 20, 2025 at 7:15 PM
Honored to be named among the Top 2% of Scientists worldwide (2025) in the @stanfordpress.bsky.social University & @elsevierconnect.bsky.social global database. Even more special to be one of only 16 scientists from Hamad Medical Corporation to receive this recognition. 💙💚
Thrilled to share that my letter to the editor titled "Data Endowment as a Digital Waqf: An Islamic Ethical Framework for AI Development" has been accepted for publication in Philosophy & Technology (Q1 journal).
May 13, 2025 at 7:30 PM
Thrilled to share that my letter to the editor titled "Data Endowment as a Digital Waqf: An Islamic Ethical Framework for AI Development" has been accepted for publication in Philosophy & Technology (Q1 journal).
I'm pleased to share our latest letter to the editor which has been recently accepted by the Asian Journal of Psychiatry (Q1, IF: 3.8)
April 10, 2025 at 7:31 PM
I'm pleased to share our latest letter to the editor which has been recently accepted by the Asian Journal of Psychiatry (Q1, IF: 3.8)
This editorial addresses the urgent and multifaceted issue of zero-dose children who have not received routine vaccinations. These children are predominantly found in marginalized communities, conflict zones, and areas with limited healthcare infrastructure.
@unicef.org
@who.int
@unicef.org
@who.int
April 10, 2025 at 7:30 PM
This editorial addresses the urgent and multifaceted issue of zero-dose children who have not received routine vaccinations. These children are predominantly found in marginalized communities, conflict zones, and areas with limited healthcare infrastructure.
@unicef.org
@who.int
@unicef.org
@who.int
I’m thrilled to share that our latest multi-country study titled “Exploring Glucagon-Like Peptide-1 Receptor Agonists Usage Among Non-Diabetic Healthcare Providers: A Cross-Sectional Multi-Country Study” has been officially accepted for publication in Health Science Reports.
March 28, 2025 at 11:19 AM
I’m thrilled to share that our latest multi-country study titled “Exploring Glucagon-Like Peptide-1 Receptor Agonists Usage Among Non-Diabetic Healthcare Providers: A Cross-Sectional Multi-Country Study” has been officially accepted for publication in Health Science Reports.
Congratulations to everyone who matched! Your hard work and dedication have paid off, and this is just the beginning of an exciting new chapter. Wishing you all the best as you take this next step in your journey!
#Match2025
#Match2025
March 17, 2025 at 8:14 PM
Congratulations to everyone who matched! Your hard work and dedication have paid off, and this is just the beginning of an exciting new chapter. Wishing you all the best as you take this next step in your journey!
#Match2025
#Match2025
I had the privilege of speaking at the Empowering AI and Research Application event, discussing the role of artificial intelligence in transforming nursing research and EBP. It was an inspiring gathering of experts, exchanging insights on AI’s impact on research, ethics, and open access.
March 5, 2025 at 5:29 PM
I had the privilege of speaking at the Empowering AI and Research Application event, discussing the role of artificial intelligence in transforming nursing research and EBP. It was an inspiring gathering of experts, exchanging insights on AI’s impact on research, ethics, and open access.